Skip to main content
. 2017 Apr 14;6(4):e005335. doi: 10.1161/JAHA.116.005335

Table 1.

Distribution of Demographic and Clinical Variables for CABG Patients by BMI Groups

Characteristics Normal (18.5–24.9) Overweight (25.0–29.9) Obese Class I (30.0–34.9) Obese Class II (35.0–39.9) Obese Class III (≥40.0) P Value
Participants, No. (%) 1509 (20) 3080 (40.7) 1942 (25.7) 696 (9.2) 333 (4.3)
Age (SD), y 68.8 (10.6) 67.2 (10.4)a 65.8 (9.8)a 63.5 (9.6)a 62.0 (9.3)a <0.001
Men, No. (%) 1167 (77.3) 2598 (84.4)a 1592 (82.0)a 544 (78.2) 252 (75.7) <0.001
Height, mean (SD), cm 170.2 (12.1) 171.1 (11.0)a 171.0 (8.9) 169.5 (14.8) 167.6 (11.7)a <0.001
Weigh, mean (SD), kg 67.2 (8.9) 80.8 (9.1)a 94.3 (10.5)a 107.7 (12.4)a 125.4 (19.8)a <0.001
Concomitant disease, No. (%)
Cerebrovascular disease 141 (9.3) 229 (7.4)a 112 (5.8)a 45 (6.5)a 25 (7.5) 0.002
Congestive heart failure 151 (10.0) 268 (8.7) 166 (8.6) 63 (9.1) 37 (11.1) 0.350
Diabetes mellitus 383 (25.4) 1006 (32.7)a 795 (40.9)a 357 (51.3)a 208 (62.5)a <0.001
Dialysis 35 (2.3) 37 (1.2)a 18 (0.9)a 8 (1.2) 8 (2.4) 0.003
Hyperlipidemia 1196 (79.3) 2535 (82.3)a 1678 (86.4)a 612 (87.9)a 287 (86.2)a <0.001
Hypertension 1048 (69.5) 2334 (75.8)a 1597 (82.2)a 593 (85.2)a 285 (85.6)a <0.001
Liver or gastrointestinal disease 49 (3.3) 115 (3.7) 62 (3.2) 26 (3.7) 8 (2.4) 0.629
Malignancy 29 (1.9) 64 (2.1) 51 (2.6) 14 (2.0) 5 (1.5) 0.515
Peripheral vascular disease 222 (14.7) 328 (10.7)a 205 (10.6)a 73 (10.5)a 29 (8.7)a <0.001
Pulmonary disease 163 (10.8) 300 (9.7) 189 (9.7) 85 (12.2) 51 (15.3)a 0.008
Renal disease 105 (7.0) 200 (6.5) 120 (6.2) 60 (8.6) 26 (7.8) 0.208
Smoking status, No. (%) b b b b <0.001
Never 301 (20.0) 563 (18.3) 332 (17.1) 123 (17.7) 65 (19.5)
Former smoker 479 (31.7) 1223 (39.7) 823 (42.4) 314 (45.1) 134 (40.2)
Current smoker 433 (28.7) 717 (23.3) 477 (24.6) 140 (20.1) 72 (21.6)
Unknown 296 (19.6) 577 (18.7) 310 (16.0) 119 (17.1) 62 (18.6)
Prior event/treatment, No. (%)
CABG 2 (0.1) 5 (0.2) 8 (0.4) 0 (0) 0 (0) 0.133
Myocardial infarction 312 (20.7) 651 (21.1) 462 (23.8) 143 (20.6) 80 (24.0) 0.090
Percutaneous coronary intervention 181 (12.0) 472 (15.3)a 321 (16.5)a 95 (13.7) 57 (17.1)a 0.002
Indication for catheterization b b b <0.001
Stable angina 597 (39.6) 1365 (44.3) 935 (48.2) 313 (45.0) 158 (47.5)
Myocardial infarction 564 (37.4) 1054 (34.2) 649 (33.4) 238 (34.2) 115 (34.5)
Unstable angina 205 (13.6) 435 (14.1) 247 (12.7) 90 (12.9) 49 (14.7)
Other 143 (9.5) 226 (7.3) 111 (5.7) 55 (7.9) 11 (3.3)
Ejection fraction, No. (%) b b 0.039
>50% 523 (34.7) 1156 (37.5) 778 (40.1) 275 (39.5) 128 (38.4)
35% to 50% 301 (20.0) 606 (19.7) 379 (19.5) 137 (19.7) 64 (19.2)
20% to 34% 80 (5.3) 164 (5.3) 94 (4.8) 30 (4.3) 22 (6.6)
<20% 28 (1.9) 37 (1.2) 23 (1.8) 5 (0.7) 8 (2.4)
Not performed 232 (15.4) 414 (13.4) 230 (11.8) 78 (11.2) 34 (10.2)
Missing 345 (22.9) 703 (22.8) 438 (22.6) 171 (24.6) 77 (23.1)
Extent of coronary disease, No. (%) 0.067
Low risk 255 (16.9) 438 (14.2) 258 (13.3) 100 (14.4) 43 (12.9)
High risk 1238 (82.0) 2607 (84.7) 1667 (85.9) 587 (84.3) 288 (86.5)
Missing 16 (1.1) 35 (1.1) 17 (0.9) 9 (1.3) 2 (0.6)

CABG indicates coronary artery bypass graft surgery. Low risk indicates lesions with <50% stenosis, 1‐ or 2‐vessel disease. High risk indicates 2‐vessel disease with proximal left anterior descending artery or left main artery disease, 3‐vessel disease or left main artery disease.

a

Subgroup significantly different from the normal BMI group (P<0.05).

b

Significant difference in the distribution of the categories compared with normal BMI.